User profiles for Daniel P. Russo

Daniel P. Russo

Post-Doctoral Researcher, Rutgers University
Verified email at scarletmail.rutgers.edu
Cited by 2382

Exploiting machine learning for end-to-end drug discovery and development

S Ekins, AC Puhl, KM Zorn, TR Lane, DP Russo… - Nature materials, 2019 - nature.com
A variety of machine learning methods such as naive Bayesian, support vector machines and
more recently deep neural networks are demonstrating their utility for drug discovery and …

Comparison of deep learning with multiple machine learning methods and metrics using diverse drug discovery data sets

A Korotcov, V Tkachenko, DP Russo… - Molecular …, 2017 - ACS Publications
Machine learning methods have been applied to many data sets in pharmaceutical
research for several decades. The relative ease and availability of fingerprint type molecular …

[HTML][HTML] T4 report: Toward good read-across practice (GRAP) guidance

…, D Pamies, M Penman, AN Richarz, DP Russo… - Altex, 2016 - ncbi.nlm.nih.gov
Grouping of substances and utilizing read-across of data within those groups represents an
important data gap filling technique for chemical safety assessments. Categories/analogue …

CATMoS: collaborative acute toxicity modeling suite

…, C Rowlands, P Ruiz, DP Russo… - Environmental …, 2021 - ehp.niehs.nih.gov
Background: Humans are exposed to tens of thousands of chemical substances that need to
be assessed for their potential toxicity. Acute systemic toxicity testing serves as the basis for …

Comparing multiple machine learning algorithms and metrics for estrogen receptor binding prediction

DP Russo, KM Zorn, AM Clark, H Zhu… - Molecular …, 2018 - ACS Publications
Many chemicals that disrupt endocrine function have been linked to a variety of adverse
biological outcomes. However, screening for endocrine disruption using in vitro or in vivo …

[HTML][HTML] Analysis of Draize eye irritation testing and its prediction by mining publicly available 2008–2014 REACH data

T Luechtefeld, A Maertens, DP Russo, C Rovida, H Zhu… - Altex, 2016 - ncbi.nlm.nih.gov
Public data from ECHA online dossiers on 9,801 substances encompassing 326,749
experimental key studies and additional information on classification and labeling were made …

Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery

T Lane, DP Russo, KM Zorn, AM Clark… - Molecular …, 2018 - ACS Publications
Tuberculosis is a global health dilemma. In 2016, the WHO reported 10.4 million incidences
and 1.7 million deaths. The need to develop new treatments for those infected with …

Predicting nano–bio interactions by integrating nanoparticle libraries and quantitative nanostructure activity relationship modeling

W Wang, A Sedykh, H Sun, L Zhao, DP Russo… - ACS …, 2017 - ACS Publications
The discovery of biocompatible or bioactive nanoparticles for medicinal applications is an
expensive and time-consuming process that may be significantly facilitated by incorporating …

Revealing adverse outcome pathways from public high-throughput screening data to evaluate new toxicants by a knowledge-based deep neural network approach

HL Ciallella, DP Russo, LM Aleksunes… - … science & technology, 2021 - ACS Publications
Traditional experimental testing to identify endocrine disruptors that enhance estrogenic
signaling relies on expensive and labor-intensive experiments. We sought to design a …

Nonanimal models for acute toxicity evaluations: Applying data-driven profiling and read-across

DP Russo, J Strickland, AL Karmaus… - Environmental …, 2019 - ehp.niehs.nih.gov
Background: Low-cost, high-throughput in vitro bioassays have potential as alternatives to
animal models for toxicity testing. However, incorporating in vitro bioassays into chemical …